Australia - engelsk - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - benserazide hydrochloride, quantity: 28.5 mg (equivalent: benserazide, qty 25 mg); levodopa, quantity: 100 mg - capsule, hard - excipient ingredients: mannitol; indigo carmine; iron oxide yellow; hypromellose; titanium dioxide; magnesium stearate; purified talc; gelatin; hydrogenated vegetable oil; povidone; calcium hydrogen phosphate dihydrate; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; iron oxide red; ethanol absolute; potassium hydroxide; ammonia - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism. madopar hbs is indicated for patients presenting with all types of fluctuations in response (i.e. "peak dose dyskinesia" and "end of dose deterioration") and for better control of nocturnal symptoms.

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

roche sa-nv - lévodopa 200 mg; chlorhydrate de bensérazide 57 mg - eq. bensérazide 50 mg - comprimé - 200 mg - 50 mg - lévodopa 200 mg; chlorhydrate de bensérazide 57 mg - levodopa and decarboxylase inhibitor

Malta - engelsk - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - benserazide, levodopa - dispersible tablet - benserazide 25 mg levodopa 100 mg - anti-parkinson drugs

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - benserazide hydrochloride, quantity: 14.25 mg (equivalent: benserazide, qty 12.5 mg); levodopa, quantity: 50 mg - tablet, dispersible - excipient ingredients: magnesium stearate; pregelatinised maize starch; citric acid; microcrystalline cellulose - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

Indonesia - indonesisk - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

boehringer ingelheim indonesia - indonesia - benserazide hydrochloride, levodopa - tablet dispersible - 28.5 mg /100 mg

Indonesia - indonesisk - Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

boehringer ingelheim indonesia - indonesia - benserazide hydrochloride; levodopa - tablet dispersible - 100/25 mg

Sverige - svensk - Läkemedelsverket (Medical Products Agency)

orifarm healthcare a/s - benserazidhydroklorid; levodopa - tablett - 100 mg/25 mg - benserazidhydroklorid 28,54 mg aktiv substans; mannitol hjälpämne; levodopa 100 mg aktiv substans

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - benserazide hydrochloride 50mg;  ; levodopa 200mg;   - tablet - 250 mg - active: benserazide hydrochloride 50mg   levodopa 200mg  

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - benserazide hydrochloride 25mg;  ;  ; levodopa 100mg;   - dispersible tablet - 125 mg - active: benserazide hydrochloride 25mg     levodopa 100mg   excipient: citric acid magnesium stearate maize starch microcrystalline cellulose

Canada - engelsk - Health Canada

hoffmann-la roche limited - levodopa; benserazide (benserazide hydrochloride) - capsule - 100mg; 25mg - levodopa 100mg; benserazide (benserazide hydrochloride) 25mg - dopamine precursors